A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well
Clinical trial NCT05495581 · COMPLETED
Trial details
- NCT number
- NCT05495581
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-25
- Primary completion
- 2023-04-27
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.